CAS: 15823-89-9 - imolamine hydrochloride
Fórmula:C14H21ClN4O
InChI:InChI=1S/C14H20N4O.ClH/c1-3-17(4-2)10-11-18-13(16-19-14(18)15)12-8-6-5-7-9-12;/h5-9,15H,3-4,10-11H2,1-2H3;1H
Chave InChI:InChIKey=OMMBWIJMWMSGBX-UHFFFAOYSA-N
SMILES:Cl.N=C1ON=C(C=2C=CC=CC2)N1CCN(CC)CC
- Sinónimos:
- 1,2,4-Oxadiazole-4(5H)-ethanamine, N,N-diethyl-5-imino-3-phenyl-, hydrochloride (1:1)
- 1,2,4-Oxadiazole-4(5H)-ethanamine, N,N-diethyl-5-imino-3-phenyl-, monohydrochloride
- 1,2,4-Oxadiazole-4(5H)-ethanimine, N,N-diethyl-5-imino-3-phenyl-, monohydrochloride (9CI)
- Angolon
- Imolamine HCl
- Irri-Cor
- Irrigor
- La 1211
- N,N-diethyl-2-[(5Z)-5-imino-3-phenyl-1,2,4-oxadiazol-4(5H)-yl]ethanamine
- Phenyl-3 imino-5 diethylaminoethyl-4 oxadiazol-1,2,4
- Ver mais sinónimos
- Phenyl-3 imino-5 diethylaminoethyl-4 oxadiazol-1,2,4 [French]
- delta(sup 2)-1,2,4-Oxadiazoline, 4-(2-(diethylamino)ethyl)-5-imino-3-phenyl-, monohydrochloride
- Δ<sup>2</sup>-1,2,4-Oxadiazoline, 4-[2-(diethylamino)ethyl]-5-imino-3-phenyl-, monohydrochloride
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Imolamine hydrochloride REF: 3D-QAA82389CAS: 15823-89-9 | Min. 95% | A consultar | Qua 22 Jan 25 | |
Imolamine hydrochloride REF: TM-T70423CAS: 15823-89-9 | - - - | 2.430,00 €~4.349,00 € | Qua 12 Mar 25 |
Imolamine hydrochloride
CAS:15823-89-9
Please enquire for more information about Imolamine hydrochloride including the price, delivery time and more …
Fórmula:
C14H21ClN4O
Pureza:
Min. 95%
Peso molecular:
296.79 g/mol
Ref: 3D-QAA82389
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 22 de Janeiro de 2025
Imolamine hydrochloride
CAS:15823-89-9
Imolamine hydrochloride is a blood platelet aggregation antagonist.
Fórmula:
C14H21ClN4O
Cor e Forma:
Liquid
Peso molecular:
296.8
Ref: TM-T70423
25mg | 2.430,00 € | ||
50mg | 3.195,00 € | ||
100mg | 4.349,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 12 de Março de 2025